Best Blood Pressure Medications for Athletes
Evidence-based guide to antihypertensive medications that preserve exercise capacity, VO2max, and athletic performance while effectively lowering blood pressure.
Cardiometabolic
22 source-based articles maintained by the HealthRX.com Editorial Team.
22articles
6topic areas covered
May 25, 2026latest review
Cardiometabolic library
Showing 22 of 22 clinical reviews.
Beta Blocker Bradycardia: Causes, Risk Factors, and When to Act
Beta blockers lower heart rate by design, but bradycardia becomes a clinical problem when the rate drops too far. Learn the thresholds, drug interactions, and management steps backed by trial data.
Bisoprolol and Statins Together: Safety, Dosing, Interactions
Bisoprolol pairs safely with atorvastatin or rosuvastatin, addressing heart rate and lipid risk together. See dosing, interactions, and monitoring guidance.
BP 180/120: AHA Hypertensive Crisis Symptoms & Emergency Signs
180/120 mmHg is a hypertensive crisis. Learn AHA symptoms that mean call 911 vs same-day care, and why BP drops slowly in an emergency.
Carvedilol vs Metoprolol: Heart Failure Trial Data Compared
Carvedilol blocks alpha-1 and beta receptors; metoprolol succinate is beta-1 selective. Both cut heart failure mortality by about 34-35% in trials.
Cost of PCSK9 Inhibitors: Pricing for Repatha, Praluent, and Leqvio in 2026
A clinical breakdown of PCSK9 inhibitor costs, including evolocumab (Repatha), alirocumab (Praluent), and inclisiran (Leqvio). Covers list prices, net prices, insurance coverage, patient assistance programs, and how these drugs compare to generic statins.
Generic Statin Pricing: What Every Patient Should Know in 2026
A detailed breakdown of generic statin costs, PCSK9 inhibitor pricing, and inclisiran expenses. Compare atorvastatin, rosuvastatin, and simvastatin prices with and without insurance.
Inclisiran (Leqvio): How It Compares to Statins for LDL Reduction
A complete clinical guide to inclisiran (Leqvio), a twice-yearly PCSK9 siRNA injection, compared with atorvastatin, rosuvastatin, simvastatin, and ezetimibe for LDL-C lowering and cardiovascular risk reduction.
Inclisiran Price: $3,250 per Injection, $6,500 Yearly
Inclisiran (Leqvio) costs about $3,250 per injection, roughly $6,500 per year. Covered under Medicare Part B, with co-pay assistance available for eligible patients.
Is Carvedilol a Statin? No, It's a Beta-Blocker
Carvedilol is not a statin. It's a beta-blocker for heart failure and hypertension, often taken with statins like atorvastatin for full cardiometabolic care.
Lipitor vs Niaspan: Why Statins Won Out Over Niacin
Niacin raises HDL and cuts triglycerides, but AIM-HIGH and HPS2-THRIVE found no added heart benefit over statins like Lipitor, plus more side effects.
Lisinopril, Statins, and Ezetimibe: A Complete Cardiometabolic Drug Guide
A guide to lisinopril, atorvastatin (Lipitor), rosuvastatin (Crestor), simvastatin (Zocor), and ezetimibe (Zetia): how each drug works, what the trials show, dosing, side effects, and how they fit together in a cardiometabolic treatment plan.
Nexletol and Nexlizet Mechanism of Action Explained
Bempedoic acid inhibits ATP-citrate lyase to lower LDL-C 21-24% alone or 36-38% with ezetimibe (Nexlizet), cutting MACE 13% in statin-intolerant patients.
Nexlizet vs Statins: How They Compare for LDL and Heart Risk
Nexlizet (bempedoic acid) lowers LDL-C 18-25%, less than statins' 30-55%, but cuts CV events per CLEAR Outcomes for statin-intolerant patients.
Patients on GLP-1s: What Clinicians and Users Need to Know Across Populations
A clinical overview of GLP-1 receptor agonist therapy across key patient populations including type 2 diabetes, older adults, women, and pregnancy considerations.
Pregnancy and Cardiometabolic Health: Gestational Diabetes, GLP-1s, and What Every Pregnant Patient Needs to Know
A guide to cardiometabolic conditions in pregnancy, covering gestational diabetes management, GLP-1 receptor agonist safety, glucose targets, and long-term cardiovascular risk after delivery.
Rivaroxaban (Xarelto): Uses, Dosing, Side Effects, and How It Compares to Other Blood Thinners
A guide to rivaroxaban (Xarelto): approved indications, dosing by indication, bleeding risks, drug interactions with statins like atorvastatin and rosuvastatin, and what the ROCKET AF and EINSTEIN trials actually showed.
Spironolactone for Blood Pressure: How It Works, Doses, and How It Fits With Statins
A guide to spironolactone for blood pressure control, including how it compares with atorvastatin, rosuvastatin, simvastatin, and ezetimibe in a full cardiometabolic treatment plan.
Statin Dose Comparison: Read Intensity Without Assuming Equivalence
Compare statin intensity without assuming exact dose equivalence, and learn why interactions, kidney function, and individual response matter.
Switching Anticoagulants: A Clinical Guide to Safe Transitions
A guide to switching anticoagulants safely, including warfarin-to-DOAC transitions, DOAC-to-DOAC switches, bridging protocols, INR timing, statin dose equivalence, and blood pressure medication titration during anticoagulation changes.
Vascepa vs Lipitor: They Work Together, Not Against
Vascepa isn't a statin swap for Lipitor. Added at 4g/day to statin therapy, it cut MACE by 25% in REDUCE-IT by targeting residual triglycerides.
What Is a Good ApoB Level?
Learn what a good apolipoprotein B (ApoB) level is, why it matters more than standard cholesterol panels, and how to lower it with lifestyle changes, statins, and other therapies.